David Sanford, Hagop Kantarjian, Jeffrey Skinner, Elias Jabbour, Jorge Cortes. Phase II trial of ponatinib in patients with chronic myeloid leukemia resistant to one previous tyrosine kinase inhibitor. haematol [Internet]. 2015Nov.30 [cited 2024Dec.22];100(12):e494-e495. Available from: https://haematologica.org/article/view/7591